Schatz & Nobel, P.C. Announces Class Action Lawsuit Against Biovail Corporation and Others HARTFORD, Conn., Nov. 13 /PRNewswire/ -- A lawsuit seeking class action status has been filed in the United States District Court for the Southern District of New York on behalf of all persons who purchased the common shares of Biovail Corporation (NYSE: BVF; TSX: BVF) ("Biovail" or the "Company") between February 7, 2003 and October 30, 2003 (the "Class Period" or the "Class") for violations of the federal securities laws. Biovail's common shares are traded on the New York Stock Exchange and on the Toronto Stock Exchange under the symbol "BVF." Plaintiff is represented by the law firm of Schatz & Nobel, P.C., which has significant experience prosecuting class actions on behalf of investors. If you wish to discuss this action or have any questions, please contact attorney Andrew M. Schatz, Jeffrey S. Nobel, or Nancy A. Kulesa at (800) 797- 5499, or by e-mail at . For more information about Schatz & Nobel, P.C. and class action cases, please visit our website: http://www.snlaw.net/. The Complaint alleges that Biovail and certain of its officers and directors made materially false and misleading statements during the Class Period. Specifically, Defendants made material misrepresentations concerning Biovail's financial results and business by, inter alia, improperly reporting revenue and earnings attributable to the sales of a generic version of Prilosec and misstating the demand in the marketplace for that product. Plaintiff further alleges that these material misrepresentations artificially inflated the price of Biovail's common shares, which traded as high as $50.30 on the New York Stock Exchange and as high as CD $67.75 on the Toronto Stock Exchange during the Class Period. Plaintiff seeks to recover damages on behalf of all Class Members, including Class Members that purchased Biovail common shares on the Toronto Stock Exchange. If you purchased or otherwise acquired Biovail common shares between February 7, 2003 and October 30, 2003, and wish to act as a lead plaintiff, you may move the Court to act in that capacity not later than January 12, 2004. If you wish to discuss your rights as lead plaintiff or as a class member, please contact Schatz & Nobel, P.C. toll-free at (800) 797- 5499, or by e-mail at . CONTACT: Andrew M. Schatz Jeffrey S. Nobel Nancy A. Kulesa Tel.: (800) 797-5499 Website: http://www.snlaw.net/ e-mail: DATASOURCE: Schatz & Nobel, P.C. CONTACT: Andrew M. Schatz, Jeffrey S. Nobel or Nancy A. Kulesa, all of Schatz & Nobel, P.C., +1-800-797-5499, Web site: http://www.snlaw.net/

Copyright